Skip Navigation
Mortar_and_pestel

Regimen Information

For Doxil, including Side Effects

Doxil

Drugs in this Regimen:

For the treatment of Breast Cancer

How Doxil chemotherapy is given and possible side effects.

Doxil for the treatment of Breast Cancer

Doxil (doxorubicin liposomal) is the drug used in the treatment of breast cancer

MOST COMMON SIDE EFFECTS OF DOXIL

  • Anemia

  • Nausea & Vomiting

  • Hand Foot Syndrome

  • Mouth Sores

For more information, see the 'Expert Resources' tab below.

Community Responses

Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.

What side effects did you experience while on this medication?

Hi, I'm judy

I received this for seven weeks and this was a very tough chemo for me as far as nausea. They finally gave me a medicine with the chemo that kept me from vomitting more or less. It was suppose to be for nausea but the day upong taking it I would feel like I had to be sick but I could not, it kept me from doing that. After the first day I felt much better and it did help me feel like I could eat and not feel nausious. But on the whole I felt not like myself.

  • Thu Nov 8, 2012

This discussion needs your voice!

What were the specific side effects that you experienced while taking this medication? How did you manage them?

What coping tips would you give to new patients on this regimen?

There are currently no answers to this question. Be the first to answer!

This discussion needs your voice!

What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?

Treatment Overview

This chemotherapy regimen is commonly used to treat:

See Expert Resources

The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the the National Cancer Institute and other experts.